Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA
✍ Scribed by Sergei Streltsov; Vladimir Oleinikov; Mikhail Ermishov; Konstantin Mochalov; Alyona Sukhanova; Yuri Nechipurenko; Sergei Grokhovsky; Alexei Zhuze; Michel Pluot; Igor Nabiev
- Publisher
- Wiley (John Wiley & Sons)
- Year
- 2003
- Tongue
- English
- Weight
- 201 KB
- Volume
- 72
- Category
- Article
- ISSN
- 0006-3525
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Topotecan (TPT), a water‐soluble derivative of camptothecin, is a potent antitumor poison of human DNA topoisomerase I (top1) that stabilizes the cleavage complex between the enzyme and DNA. The role of the recently discovered TPT affinity to DNA remains to be defined. The aim of this work is to clarify the molecular mechanisms of the TPT‐DNA interaction and to propose the models of TPT‐DNA complexes in solution in the absence of top1. It is shown that TPT molecules form dimers with a dimerization constant of (4.0 ± 0.7) × 10^3^M^−1^ and the presence of DNA provokes more than a 400‐fold increase of the effective dimerization constant. Flow linear dichroism spectroscopy accompanied by circular dichroism, fluorescence, and surface‐enhanced Raman scattering experiments provide evidence that TPT dimers are able to bind DNA by bridging different DNA molecules or distant DNA structural domains. This effect may provoke modification of the intrinsic geometry of the cruciform DNA structures, leading to the appearance of new crossover points that serve as the sites of the top1 loading position. The data presume the hypothesis of TPT‐mediated modulation of top1‐DNA recognition before ternary complex formation. © 2003 Wiley Periodicals, Inc. Biopolymers (Biospectroscopy), 2003